A method is disclosed for treating nephropathies involving undesired alternative pathway complement activation by administration of a complement inhibitory protein such as soluble complement receptor type I (sCR1).
Patent
Treatment of chronic nephropathies using soluble complement receptor type I (sCR1)
United States Patent and Trademark Office
05/16/2017
Abstract
Details
- Title: Subtitle
- Treatment of chronic nephropathies using soluble complement receptor type I (sCR1)
- Creators
- Richard J H Smith (Inventor)Yuzhou Zhang (Inventor)Henry C Marsh (Inventor)
- Contributors
- Celldex Therapeutics, Inc. (Needham, MA, US) (Assignee)University of Iowa Research Foundation (Iowa City, IA, US) (Assignee)
- Resource Type
- Patent
- Publisher
- United States Patent and Trademark Office; United States
- Patent
- US Patent 9,649,357; Published; 15/071,504; 03/16/2016; 1/1
- Number of pages
- 25 pages
- Language
- English
- Date published
- 05/16/2017
- Academic Unit
- Iowa Neuroscience Institute; UI Research Foundation; Otolaryngology
- Record Identifier
- 9983761950002771
Metrics
15 File views/ downloads
23 Record Views